Benzinga's Top Upgrades, Downgrades For May 3, 2019 - Allogene Therapeutics (NASDAQ:ALLO)

Analysts at Deutsche Bank upgraded Tripadvisor Inc TRIP from Hold to Buy. TripAdvisor shares gained 1.8 percent to $53.40 in pre-market trading.
Bernstein upgraded Walmart Inc WMT from Market Perform to Outperform. Walmart shares rose 0.6 percent to $101.80 in pre-market trading.
Barclays upgraded Bristol-Myers Squibb Co BMY from Equal-Weight to Overweight. Bristol-Myers shares rose 0.8 percent to $47.27 in pre-market trading.
Deutsche Bank upgraded Exantas Capital Corp XAN from Hold to Buy. Exantas Capital shares rose 1.3 percent to $11.54 in pre-market trading.
B. Riley upgraded Hercules Capital Inc HTGC from Neutral to Buy. Hercules Capital shares rose 2.2 percent to $13.20 in pre-market trading.
Wells Fargo upgraded Intercept Pharmaceuticals Inc ICPT from Market Perform to Outperform. Intercept Pharmaceuticals shares rose 2.1 percent to $90.02 in pre-market trading.
Analysts at Goldman Sachs upgraded Domtar Corp UFS from Neutral to Buy. Domtar shares fell 0.9 percent to close at $45.13 on Thursday.
Raymond James upgraded NexPoint Residential Trust Inc NXRT from Outperform to Strong Buy. NexPoint Residential fell 1.57 percent to close at $37.52 on Thursday.
Analysts at Jefferies upgraded Tilray Inc TLRY from Underperform to Hold. Tilray rose 2.1 percent to $51.30 in pre-market trading.
Wedbush upgraded MacroGenics Inc MGNX from Neutral to Outperform. MacroGenics shares rose 5 percent to $18.21 in pre-market trading.

Citigroup downgraded Fortinet Inc FTNT from Neutral to Sell. Fortinet shares fell 5 percent to $87.00 in pre-market trading.
Bernstein downgraded Target Corporation TGT from Outperform to Market Perform. Target shares fell 0.5 percent to $76.05 in pre-market trading.
Barclays downgraded Incyte Corporation INCY from Overweight to Equal-Weight. Incyte shares rose 1 percent to $81.75 in pre-market trading.
Raymond James downgraded Bottomline Technologies EPAY from Strong Buy to Outperform. Bottomline Technologies shares fell 7.7 percent to $46.50 in pre-market trading.
Goldman Sachs downgraded Yeti Holdings Inc YETI from Buy to Neutral. YETI shares fell 0.6 percent to $30.76 in pre-market trading.
Baird downgraded Cambrex Corporation CBM from Outperform to Neutral. Cambrex shares rose 0.93 percent to close at $43.47 on Thursday.
Barclays downgraded Achillion Pharmaceuticals, Inc. ACHN from Equal-Weight to Underweight. Achillion Pharmaceuticals shares fell 2.7 percent to $2.93 in pre-market trading.
JP Morgan downgraded Cognizant Technology Solutions Corp CTSH from Neutral to Underweight. Cognizant shares fell 7.8 percent to $61.39 in pre-market trading.
Citigroup downgraded Church & Dwight Co., Inc. CHD from Neutral to Sell. Church & Dwight shares fell 1.2 percent to $73.80 in pre-market trading.
Barclays downgraded Celgene Corporation CELG from Overweight to Equal-Weight. Celgene shares rose 0.3 percent to $95.49 in pre-market trading.

H.C. Wainwright assumed coverage on Collegium Pharmaceutical Inc COLL with a Buy rating. The price target for Collegium Pharmaceutical is set to $23. Collegium Pharmaceutical shares closed at $13.90 on Thursday.
Analysts at Maxim Group initiated coverage on Craft Brew Alliance Inc BREW with a Buy rating. The price target for Craft Brew Alliance is set to $21. Craft Brew Alliance closed at $14.45 on Thursday.
Atlantic Equities initiated coverage on Uber Technologies UBER with a Neutral rating.
Oppenheimer initiated coverage on AllogeAllogene Therapeutics Inc ALLO with an Outperform rating. The price target for Allogene Therapeutics is set to $45. Allogene Therapeutics closed at $29.72 on Thursday.
Seaport Global initiated coverage on CContura Energy Inc CTRA with a Buy rating. The price target for Contura Energy is set to $78. Contura Energy closed at $56.63 on Thursday.
Atlantic Equities initiated coverage on LYFT Inc LYFT with a Underweight rating. Lyft closed at $61.50 on Thursday.